HUP2100005A1 - Rheumatoid arthrits páciensek biológiai terápiára adott válasz készségének becslése - Google Patents
Rheumatoid arthrits páciensek biológiai terápiára adott válasz készségének becsléseInfo
- Publication number
- HUP2100005A1 HUP2100005A1 HU2100005A HUP2100005A HUP2100005A1 HU P2100005 A1 HUP2100005 A1 HU P2100005A1 HU 2100005 A HU2100005 A HU 2100005A HU P2100005 A HUP2100005 A HU P2100005A HU P2100005 A1 HUP2100005 A1 HU P2100005A1
- Authority
- HU
- Hungary
- Prior art keywords
- rheumatoid arthritis
- biological treatment
- arthritis patients
- assessing responsiveness
- responsiveness
- Prior art date
Links
- 230000004043 responsiveness Effects 0.000 title 1
- 206010039073 rheumatoid arthritis Diseases 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18172478.2A EP3570028A1 (en) | 2018-05-15 | 2018-05-15 | Assessing responsiveness of rheumatoid arthritis patients to biological treatment |
HU1800184A HUP1800184A1 (hu) | 2018-05-30 | 2018-05-30 | Rheumatoid arthritis betegek biológiai terápiára adott válasz készségének becslése |
PCT/HU2019/050025 WO2019220158A1 (en) | 2018-05-15 | 2019-05-15 | Assessing responsiveness of rheumatoid arthritis patients to biological treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP2100005A1 true HUP2100005A1 (hu) | 2021-03-29 |
Family
ID=89992700
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU2100005A HUP2100005A1 (hu) | 2018-05-15 | 2019-05-15 | Rheumatoid arthrits páciensek biológiai terápiára adott válasz készségének becslése |
Country Status (4)
Country | Link |
---|---|
US (1) | US20210382049A1 (hu) |
EP (1) | EP3794347A1 (hu) |
HU (1) | HUP2100005A1 (hu) |
WO (1) | WO2019220158A1 (hu) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU217108B (hu) | 1994-08-31 | 1999-11-29 | SOLVO Biotechnológiai Kft. | Eljárás daganatok multidrogrezisztenciáját okozó fehérje aktivitásának in vitro mennyiségi kimutatására biológiai mintákban |
WO2012061620A1 (en) | 2010-11-04 | 2012-05-10 | Genentech, Inc. | Methods for treating, diagnosing, and monitoring rheumatoid arthritis |
JPWO2015083765A1 (ja) | 2013-12-04 | 2017-03-16 | 国立大学法人大阪大学 | 生物学的製剤による関節リウマチの治療効果を予測判定する方法 |
EP2980587A1 (en) | 2014-08-01 | 2016-02-03 | Fundació Hospital Universitari Vall d' Hebron - Institut de Recerca | Method to predict response to treatment with anti-TNF alpha agents |
WO2016015779A1 (en) | 2014-08-01 | 2016-02-04 | Fundació Hospital Universitari Vall D'hebron - Institut De Recerca | Method to predict the lack of response to anti-tnf alpha therapies |
US11644473B2 (en) | 2016-04-15 | 2023-05-09 | Rowan University | Serum biomarkers for predicting and evaluating response to TNF inhibitor therapy in rheumatoid arthritis patients |
-
2019
- 2019-05-15 WO PCT/HU2019/050025 patent/WO2019220158A1/en unknown
- 2019-05-15 EP EP19742889.9A patent/EP3794347A1/en active Pending
- 2019-05-15 US US17/055,835 patent/US20210382049A1/en active Pending
- 2019-05-15 HU HU2100005A patent/HUP2100005A1/hu unknown
Also Published As
Publication number | Publication date |
---|---|
US20210382049A1 (en) | 2021-12-09 |
WO2019220158A1 (en) | 2019-11-21 |
EP3794347A1 (en) | 2021-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUE056228T2 (hu) | Biológiai szövetek számítógépes osztályozása | |
FI3204113T3 (fi) | Laite biologisen kudoksen stimulointiin | |
IL264025A (en) | Novel fatty acid-modified urocortin-2 analogs for the treatment of diabetes and chronic kidney disease | |
SG11202104222TA (en) | Method of treatment of biological surfaces | |
IL260824A (en) | Differentiation of human pluripotent stem cells into cortical neurons | |
IL254386B (en) | NK-3 receptor antagonists for medical or cosmetic treatment of excess body fat | |
MA54412A (fr) | Traitement d'excès de graisse hépatique et/ou viscérale | |
ZA202003785B (en) | Use of coriobacteriia to promote gut health | |
MA42287A (fr) | Traitement de patients atteints de diabète sucré de type 2 | |
ZA201903795B (en) | Treatment of water | |
FR3017624B1 (fr) | Methode predictive pour caracteriser la radiosensibilite et la reaction tissulaire d'un patient envers un rayonnement ionisant therapeutique | |
HUP2100005A1 (hu) | Rheumatoid arthrits páciensek biológiai terápiára adott válasz készségének becslése | |
PL3713883T3 (pl) | System do biologicznego uzdatniania wody | |
HUP1800184A1 (hu) | Rheumatoid arthritis betegek biológiai terápiára adott válasz készségének becslése | |
MA41782A (fr) | Traitement de patients atteints de diabète de type 2 | |
IL287263A (en) | Methods for diagnosing and treating rheumatoid arthritis | |
IT201700115761A1 (it) | Bioreattore per la ricellularizzazione e la stimolazione meccanica del diaframma | |
EP3599288C0 (en) | DIAGNOSIS AND TREATMENT OF PSORIATIC ARTHRITIS | |
GB201521058D0 (en) | A method of computer-assisted analysis of one or more tissue sections of the human or animal body | |
EP3615561C0 (en) | VARIANTS OF HUMAN BMP7 PROTEIN | |
FR3052669B1 (fr) | Prothese biologique destinee au traitement des hernies parastomales | |
GB201820796D0 (en) | Imaging of biological tissue | |
GB202303042D0 (en) | Assessing the response to treatment of sinusitis | |
GB201812073D0 (en) | Disslocation of biological samples | |
GB201904012D0 (en) | Regulation of blood glucoe via human microbioma |